Skip to main content

Table 1 Laboratory findings

From: Combined effect of teriparatide and low-intensity pulsed ultrasound for nonunion: a case report

  Normal value Before teriparatide administration After teriparatide administration
BAP (μg/ml) (3.7-20.9) 25.4 19.9
PINP (μg/ml) (19.5-71.2) 37.1 48.0
DPD (nmol/mmlCr) (2.1-5.4) 18.7 6.9
Serum NTX (NMOLBCE/L) (9.5-17.7) 17.6 16.6
TRACP-5B (μU/dl) (170–590) 446 272
ucOC (ng/ml) (<4.5) 18.8 5.6
Serum Hcys (nmol/ml) (3.7-13.5) 21.9 10.9
Urine Pen (μg/mgCr) (0.019-0.070) 0.042 0.023
intactPTH (pg/ml) (10–65) 57 54
25-OHVitD (ng/ml) (7–41) 7 10
Vit.B12 (pg/ml) (180–914) 700 981
Vit.B6 (ng/ml) (6–40) 7.2 15.2
Folate (ng/ml) (>3.1) 2.0 4.2
Ca (mg/dL) (8.4-9.7) 8.6 9.1
P (mg/dL) (2.5-4.5) 2.9 2.7
Cr (mg/dL) (0.6-1.2) 0.9 0.9
eGFR (ml/min/1.73 m2) (>90) 98 97
CRP (mg/dL) (<0.3) 0.0 0.0
  1. Abbreviation; BAP Bone alkaline phosphatase, PINP procollagen typeIN-terminal propeptide, DPD dihydropyrimidine dehydrogenase, NTX N-terminal crosslinking telopeptide of typeIcollagen, TRACP-5B Tartrate-resistant Acid Phosphatase type 5B, ucOC uncarboxylated osteocalcin, Hcys homocysteine, Pen pentosidine, PTH parathyroid hormone, 25-OHVitD 25-hydroxyvitamin-D, Ca calcium, P phosphorus, Cr creatinine, CRP C-reactive protein, eGFR estimated glomerular filtration rate.